Current Oncology | Collection of Title Stories in 2025

We are pleased to present a selection of title stories published in Current Oncology (ISSN: 1718-7729) during 2025. These articles highlight groundbreaking research and advancements in clinical oncology, and we hope they can provide insights and references for scholars in related fields.

1. “Advancing Research Alongside Patient Partners: Next-Generation Best Practices for Effective Collaboration in Health Research”
by Ally C. Farrell, Jessica A. Lawson, Ovarian Cancer Canada’s Patient Partners in Research Team, Alison Ross and Alicia A. Tone
Curr. Oncol. 2024, 31(11), 6956-6978; https://doi.org/10.3390/curroncol31110513
Available online: https://www.mdpi.com/1718-7729/31/11/513

2. “The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers”
by Ryan Michael Antar, Christopher Fawaz, Diego Gonzalez, Vincent Eric Xu, Arthur Pierre Drouaud, Jason Krastein, Faozia Pio, Andeulazia Murdock, Kirolos Youssef, Stanislav Sobol et al.
Curr. Oncol. 2024, 31(11), 6909-6937; https://doi.org/10.3390/curroncol31110511
Available online: https://www.mdpi.com/1718-7729/31/11/511

3. “Malignant Pleural Effusion: Diagnosis and Treatment—Up-to-Date Perspective”
by Riccardo Orlandi, Andrea Cara, Enrico Mario Cassina, Sara Degiovanni, Lidia Libretti, Emanuele Pirondini, Federico Raveglia, Antonio Tuoro, Sara Vaquer, Stefania Rizzo et al.
Curr. Oncol. 2024, 31(11), 6867-6878; https://doi.org/10.3390/curroncol31110507
Available online: https://www.mdpi.com/1718-7729/31/11/507

4. “Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting”
by Filippo de Marinis, Andrea Ardizzoni, Ilaria Attili, Laura Bonanno, Emilio Bria, Diego Luigi Cortinovis, Stefano Margaritora, Francesca Mazzoni, Edoardo Mercadante, Alessandro Morabito et al.
Curr. Oncol. 2025, 32(2), 110; https://doi.org/10.3390/curroncol32020110
Available online: https://www.mdpi.com/1718-7729/32/2/110

5. “When “One Size Fits All” Fits None: A Commentary on the Impacts of the “Draft Canadian Breast Cancer Screening Guidelines” on Racialized Populations in Canada”
by Beverley Osei, Gayathri Naganathan, Juliet M. Daniel, Supriya Kulkarni, Aisha Lofters, Yinka Oladele, Leila Springer and Mojola Omole
Curr. Oncol. 2025, 32(3), 123; https://doi.org/10.3390/curroncol32030123
Available online: https://www.mdpi.com/1718-7729/32/3/123

6. “Feasibility and Acceptability of Social Prescribing for Cancer Survivors”
by Deirdre Connolly, Chloe O’Hara, Catherine O’Brien and Adrienne Dempsey
Curr. Oncol. 2025, 32(3), 129; https://doi.org/10.3390/curroncol32030129
Available online: https://www.mdpi.com/1718-7729/32/3/129

7. “Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma”
by Andrée-Anne Pelland, Mathilde Dumas, Émilie Lemieux-Blanchard, Richard LeBlanc, Julie Côté, Jean-Samuel Boudreault, Dominic Duquette, Rayan Kaedbey, Marc Lalancette, Frédéric Larose et al.
Curr. Oncol. 2025, 32(4), 238; https://doi.org/10.3390/curroncol32040238
Available online: https://www.mdpi.com/1718-7729/32/4/238

8. “Implementation of Organ Preservation for Locally Advanced Rectal Cancer in Canada: A National Survey of Clinical Practice”
by Megan Delisle, Victoria Ivankovic, Doris Goubran, Eliane Yvonne Paglicauan, Mariam Alsobaei, Nicole Alcasid, Mary Farnand and Kristopher Dennis
Curr. Oncol. 2025, 32(6), 341; https://doi.org/10.3390/curroncol32060341
Available online: https://www.mdpi.com/1718-7729/32/6/341

9. “Parents’ Experiences and Clinicians’ Perceptions of Managing Cancer Pain in Young Children at Home”
by Lindsay A. Jibb, Elham Hashemi, Surabhi Sivaratnam, Aimee K. Hildenbrand, Paul C. Nathan, Julie Chartrand, Nicole M. Alberts, Tatenda Masama, Hannah G. Pease, Lessley B. Torres et al.
Curr. Oncol. 2025, 32(10), 538; https://doi.org/10.3390/curroncol32100538
Available online: https://www.mdpi.com/1718-7729/32/10/538

10. “Cervical Cancer Screening Cascade: A Framework for Monitoring Uptake and Retention Along the Screening and Treatment Pathway”
by Sara Izadi-Najafabadi, Laurie W. Smith, Anna Gottschlich, Amy Booth, Stuart Peacock and Gina S. Ogilvie
Curr. Oncol. 2025, 32(7), 407; https://doi.org/10.3390/curroncol32070407
Available online: https://www.mdpi.com/1718-7729/32/7/407

11. “Methylation Status of the Telomerase Reverse Transcriptase Promoter in Parotid Tumours and Adjacent Parotid Gland Tissue: A Pilot Study on the Implications for Recurrence and Development of Malignancy”
by António Paiva-Correia, Joana Apolónio, Alfons Nadal, José Ricardo Brandão, Nádia Silva, Bianca Machado, Ivan Archilla, Pedro Castelo-Branco and Henrik Hellquist
Curr. Oncol. 2025, 32(6), 312; https://doi.org/10.3390/curroncol32060312
Available online: https://www.mdpi.com/1718-7729/32/6/312

12. “Dosimetric Comparison of VMAT Alone and VMAT with HDR Brachytherapy Boost Using Clinical and Biological Dose Models in Localized Prostate Cancer”
by Manuel Guhlich, Olga Knaus, Arne Strauss, Laura Anna Fischer, Jann Fischer, Stephanie Bendrich, Sandra Donath, Leif Hendrik Dröge, Martin Leu, Stefan Rieken et al.
Curr. Oncol. 2025, 32(6), 360; https://doi.org/10.3390/curroncol32060360
Available online: https://www.mdpi.com/1718-7729/32/6/360

13. “Renal Cell Carcinoma: Prognosis in the Era of Targeted Therapy”
by Kathrin Halfter, Michael Staehler, Dieter Hölzel, Alexander Crispin and Anne Schlesinger-Raab
Curr. Oncol. 2025, 32(9), 515; https://doi.org/10.3390/curroncol32090515
Available online: https://www.mdpi.com/1718-7729/32/9/515